CT scan

Bell Law Firm and Steele Adams Hosman File Medical Malpractice Lawsuit Following the Death of 19-Year-Old Utah Woman

Retrieved on: 
Wednesday, April 12, 2023
Legal, Professional Services, Intermountain Medical Center, State, Life, Intermountain Health, Respiratory arrest, Life flight, Florida Third District Court of Appeal, MCFD, Ventilation, Wood, EMS, District court, Utah Highway Patrol, Drug, CT scan, Death, Hypoxia (medical), Nursing, IMC

As a result, Gwen rapidly went into respiratory arrest.

Key Points: 
  • As a result, Gwen rapidly went into respiratory arrest.
  • According to Alyssa Wood, an attorney at Steele Adams Hosman, the medication error is a “never event,” the type of medical error that should never occur.
  • “As a result of the overdose,” states Wood, “a young woman lost her life, and two families lost their daughter and eldest sibling.”
    “This is a tragic and egregious case of negligence,” says Lloyd Bell, an attorney at Bell Law Firm.
  • “After bypassing safety protocols, multiple EMS providers administered Gwen a massive overdose of high-risk medication.

Smiths Detection’s advanced carry-on baggage screening technology transforming Rome’s Leonardo da Vinci Airport

Retrieved on: 
Wednesday, April 12, 2023
Security, Air, Technology, Transport, Audio, Video, Hardware, STAC, ECAC, ADR, Electronics, 3D, Terminal One, Accession (property law), Multimedia, CT scan, Rome Airport, Harold Smith (detective), Automation, Smiths Group, AI, TSA, Leonardo, Level 1, Airline, Medical imaging

Italy’s largest airport, Rome’s Fiumicino International Airport ‘Leonardo da Vinci’, is seeing passengers speed through security screening following the deployment of the HI-SCAN 6040 CTiX carry-on baggage screening technology from Smiths Detection, a global leader in threat detection and security screening technologies.

Key Points: 
  • Italy’s largest airport, Rome’s Fiumicino International Airport ‘Leonardo da Vinci’, is seeing passengers speed through security screening following the deployment of the HI-SCAN 6040 CTiX carry-on baggage screening technology from Smiths Detection, a global leader in threat detection and security screening technologies.
  • Fiumicino International Airport was recently awarded 5-Star by Skytrax and has been awarded ACI Europe Best Airport four times in the last five years.
  • Smiths Detection’s leading CT checkpoint technology produces high-resolution volumetric 3D images for quicker and deeper baggage assessment, automatic explosives detection and low false-alarm rates.
  • Gabriel Pequignot, Smiths Detection Head of Market, said: “We’re delighted by the early results that we’re seeing at Rome’s Leonardo da Vinci airport.

TSA awards up to $1.3 billion to procure additional CT X-ray scanners for airport checkpoints

Retrieved on: 
Wednesday, April 12, 2023
Workforce, Analogic Corporation, CT, Freedom, Law enforcement, Aviation, Airport, Intelligence, Transportation Security Administration, Transport, CT scan, Movement, Algorithm, Commerce, TSA, Medical imaging, Baggage

"Deploying these units across our security checkpoints as expeditiously as possible will also improve checkpoint efficiency and the passenger experience."

Key Points: 
  • "Deploying these units across our security checkpoints as expeditiously as possible will also improve checkpoint efficiency and the passenger experience."
  • CT scanners apply sophisticated algorithms and create 3-D rotatable images to help operators detect explosives and prohibited items.
  • In March 2022, TSA announced two awards for a combined total value of up to $781.2 million for the procurement of base and full-size CT x-ray systems for airport checkpoints.
  • There are approximately 634 CT units currently installed, and installations continue at TSA checkpoints across the country.

Cardiovascular Clinical Sciences Names Dr. Jing Dai as New Head of Cardiac Core Lab

Retrieved on: 
Monday, April 3, 2023
Dai, CT, TMVR, Beth Israel Deaconess Medical Center, Biotechnology, Cardiovascular disease, Research, Atherosclerosis, Peking University Health Science Center, Tufts Medical Center, Publication, Contract research organization, TAVR, Stent, Knowledge, CCS, CT scan, Medical device

BOSTON, April 3, 2023 /PRNewswire/ -- As cardiac imaging becomes more integrated in both clinical practice and research, Cardiovascular Clinical Sciences (CCS) announced today the appointment of Dr. Jing Dai as the new Director of Core Lab Operations.Dr. Dai is a highly accomplished medical professional with an impressive academic background, having earned both an M.D. and Ph.D. from Peking University Health Science Center.   With expertise in angiographic and CT imaging, she has played a vital role in numerous clinical studies at Beth Israel Deaconess Medical Center, evaluating a wide range of cardiovascular devices and technologies, including bare metal stents, drug-eluting stents, bioabsorbable scaffolds, drug-coated balloons, TAVR, and TMVR devices.In addition to her clinical research experience, Dr. Dai has more than ten years of experience in the basic cardiovascular research field. Her research has made significant contributions to the understanding of the molecular mechanisms underlying atherosclerosis and dilated cardiomyopathy. Her dedication to advancing the field of cardiovascular research is reflected in her publications and her role as a reviewer for more than 20 prestigious journals."As the new Director of Core Lab Operations, Dr. Dai brings her wealth of knowledge and expertise to lead the lab's efforts to advance the understanding of cardiovascular disease and improve patient outcomes," says Dr. Lorraine Rusch, CEO of CCS.  "We are confident in her leadership, and that her dedication and extensive experience will prove invaluable to the continued success of the lab."CCS was founded in 1997 as a cardiovascular specific Contract Research Organization (CRO) by Dr. Marvin Konstam and Dr. James Udelson of Tufts Medical Center.  It has established itself as the CRO of choice for pharmaceutical, biotechnology and medical device companies looking to conduct research to manage and treat cardiovascular diseases.To learn more about CCS and services it provides the life sciences industry, please visit www.ccstrials.comContact:Dr. Lorraine Rusch, President & CEOCardiovascular Clinical Scienceslrusch@ccstrials.com914-548-1690Photo(s):https://www.prlog.org/12958273Press release distributed by PRLog

Key Points: 
  • BOSTON, April 3, 2023 /PRNewswire/ -- As cardiac imaging becomes more integrated in both clinical practice and research, Cardiovascular Clinical Sciences (CCS) announced today the appointment of Dr. Jing Dai as the new Director of Core Lab Operations.
  • Dr. Dai is a highly accomplished medical professional with an impressive academic background, having earned both an M.D.
  • In addition to her clinical research experience, Dr. Dai has more than ten years of experience in the basic cardiovascular research field.
  • To learn more about CCS and services it provides the life sciences industry, please visit www.ccstrials.com

Brain Mapping Instruments Market to Reach $3.7 Billion, Globally, by 2031 at 6.1% CAGR: Allied Market Research

Retrieved on: 
Friday, March 31, 2023
Seizure, Maintenance, Magnetic resonance, Prevalence, Alzheimer's disease, Table, Neoplasm, Hospital, Stroke, COVID-19, NIRS, PET, CT scan, DSM-IV codes, PEM, Chart, MRI, Toxic injury, Hydrocephalus, Page, Investment, Patient, Myenteric plexus, EEG, Brain mapping, Growth, PDF, Magnetic resonance imaging, Positron emission tomography, Medical imaging, Electroencephalography

PORTLAND, Ore., March 31, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Brain Mapping Instruments Market by Product Type (Computed Tomography, Positron Emission Tomography (PET), Electroencephalography (EEG), Near-Infrared Spectroscopy (NIRS), Magnetic Resonance Imaging (MRI), Others), by End User (Hospitals, Ambulatory Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global brain mapping instruments industry generated $2.1 billion in 2021 and is anticipated to generate $3.7 billion by 2031, witnessing a CAGR of 6.1% from 2022 to 2031.

Key Points: 
  • According to the report, the global brain mapping instruments industry generated $2.1 billion in 2021 and is anticipated to generate $3.7 billion by 2031, witnessing a CAGR of 6.1% from 2022 to 2031.
  • The market for brain mapping instruments is experiencing growth due to various factors such as an increase in the prevalence of brain-related conditions like Alzheimer's disease, epilepsy seizures, toxic injuries, and tumors.
  • Additionally, there is a rise in the number of neurological incidents among populations, a growing geriatric population, and increased awareness and adoption of advanced brain mapping technologies.
  • Based on region, the market in North America accounted for more than two-fifths of the global brain mapping instruments market and is likely to dominate in terms of revenue during the forecast period.

Smiths Detection launches compact CT checkpoint X-ray

Retrieved on: 
Tuesday, February 28, 2023
Other Transport, Technology, Air, Security, Transport, Software, Transportation, Hardware, Travel, Gel, Tesla Model S, CT scan, ECAC, Vibration, Smiths Group, Medical imaging, Television

Smiths Detection , a global leader in threat detection and security screening technologies, today announces that it has launched the HI-SCAN 6040 CTiX Model S , a smaller footprint version of its successful, security operator preferred, Computed Tomography (CT) passenger checkpoint scanner.

Key Points: 
  • Smiths Detection , a global leader in threat detection and security screening technologies, today announces that it has launched the HI-SCAN 6040 CTiX Model S , a smaller footprint version of its successful, security operator preferred, Computed Tomography (CT) passenger checkpoint scanner.
  • This new model, which is 20cm narrower and 350kg lighter than the HI-SCAN 6040 CTiX, can be easily integrated into existing and new airport or critical infrastructure checkpoints.
  • The HI-SCAN 6040 CTiX Model S can be seamlessly integrated alongside both Smiths Detection and third-party technology, supporting the development of open architecture solutions.
  • It can be further enhanced with Smiths Detection’s iCMORE automated object recognition software which allows for automated detection of an ever-expanding list of prohibited items, improving security outcomes and efficiency.

RapidAI Enhances Pulmonary Embolism Care Solution with FDA 510(k) Clearance for Rapid RV/LV

Retrieved on: 
Wednesday, February 22, 2023
Apps, Applications, Technology, Hospitals, Cardiology, Software, Internet, General Health, Health, Data Management, Artificial Intelligence, Quality of life, Diagnosis, Workflow, PE, Rapids, Interventional cardiology, FDA, Patient, CT scan, LV, CTPA, Communication, Physician, Pulmonary embolism, Medical device, Medical imaging, RV

RapidAI , the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA 510(k) clearance for Rapid RV/LV, the newest addition to the Rapid PE solution.

Key Points: 
  • RapidAI , the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA 510(k) clearance for Rapid RV/LV, the newest addition to the Rapid PE solution.
  • Automating this process will enable care teams to more quickly prioritize patients and accelerate decision making.
  • “The FDA clearance of Rapid RV/LV further enhances our PE solution by providing physicians with an immediate view into patients suffering from RV strain, which is critical to getting the right patients to the right care as fast as possible.
  • This will have a profound impact on our PE program here at Ascension.”
    To learn more about how RapidAI is transforming pulmonary embolism care, please visit: https://www.rapidai.com/pe

Asia Pacific Diagnostic Imaging Markets, Competition, Forecast & Opportunities, 2028 - ResearchAndMarkets.com

Retrieved on: 
Monday, January 30, 2023
Medical Devices, Health, Forecast, User (computing), Accident, Embrace Neonatal MRI System, Google Images, Country, Injury, Diagnosis, Competition, CT, Medical imaging, MRI, Mobility, CT scan, Medical tourism, Diabetes, Application, Hypertension, Ultrasound, GE HealthCare, Growth, Conditional sentence, Prevalence, Cancer, Medical device, Mammography

Growing adoption of advanced technologies in diagnostic imaging modalities is also one of the major factors for the growth of the Asia Pacific diagnostic imaging market.

Key Points: 
  • Growing adoption of advanced technologies in diagnostic imaging modalities is also one of the major factors for the growth of the Asia Pacific diagnostic imaging market.
  • The Asia Pacific diagnostic imaging market is segmented into type, mobility, source, application, end users, company and country.
  • To estimate and forecast the market size of Asia Pacific diagnostic imaging market from 2022 to 2028 and growth rate until 2028.
  • To classify and forecast Asia Pacific diagnostic imaging market based on type, mobility, source, application, end users, component, company and country distribution.

Global Computed Tomography (CT) Scanners Market to Reach $10.3 Billion by 2030

Retrieved on: 
Monday, February 13, 2023
Cloud, Climate change, CT scan, Security, Cone beam computed tomography, Ageing, Investment, CT, Low-end market, Pressure, Neurology, Food, Cardiology, Risk, Application, End-use certificate, Growth, History of computed tomography, COVID, COVID-19, Hospital, CBCT, Medical imaging, Medical device, Satellite navigation device, Rare-earth element, Floral industry, Dairy, Clothing, Speciality chemicals, Wholesaling

In the changed post COVID-19 business landscape, the global market for Computed Tomography (CT) Scanners estimated at US$6.9 Billion in the year 2022, is projected to reach a revised size of US$10.3 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2022-2030.

Key Points: 
  • In the changed post COVID-19 business landscape, the global market for Computed Tomography (CT) Scanners estimated at US$6.9 Billion in the year 2022, is projected to reach a revised size of US$10.3 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2022-2030.
  • The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 8.7% CAGR
    The Computed Tomography (CT) Scanners market in the U.S. is estimated at US$1.9 Billion in the year 2022.
  • China, the world`s second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2022 to 2030.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.4 Billion by the year 2030.

Mobile Imaging Market is expected to display a steady growth of 6% due to the rising demand for portable devices from emergency department| UnivDatos Market Insights

Retrieved on: 
Thursday, February 9, 2023
Pediatrics, Smoking, Hospital, CT scan, Canon Inc., Patient, EKG, Research, Product type, USD, WHO, Death, Magnetic resonance imaging, Internet, Growth, InHealth Group, Conditional sentence, Light, Prevalence, COVID-19, Medical imaging, Online shopping, Mammography, Cancer, Others, NOIDA, Ultrasound

This innovative report makes use of several analyses to get a closer outlook on the mobile imaging market.

Key Points: 
  • This innovative report makes use of several analyses to get a closer outlook on the mobile imaging market.
  • The Mobile Imaging market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth.
  • Furthermore, this statistical market research repository examines and estimates the Mobile Imaging market at the global and regional levels.
  • Factors such as rapid technological advancement and increasing demand for homecare facilities are important factors responsible for the market growth of the mobile imaging market.